Truist Financial
NVCR icon

Truist Financial’s NovoCure NVCR Stock Holding History

Truist Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,795
Closed -$228K – 2772
2025
Q2 		$228K Sell
12,795
-1,921
-13% -$33.5K ﹤0.01% 2358
2025
Q1 		$262K Buy
14,716
+3,294
+29% +$74.8K ﹤0.01% 2215
2024
Q4 		$340K Buy
+11,422
New +$242K ﹤0.01% 2088
2023
Q3 		– Sell
-12,638
Closed -$524K – 2644
2023
Q2 		$524K Buy
12,638
+3,502
+38% +$217K ﹤0.01% 1925
2023
Q1 		$549K Sell
9,136
-2,443
-21% -$195K ﹤0.01% 1923
2022
Q4 		$849K Buy
11,579
+647
+6% +$48.7K ﹤0.01% 1634
2022
Q3 		$831K Buy
10,932
+1,530
+16% +$119K ﹤0.01% 1574
2022
Q2 		$653K Buy
+9,402
New +$708K ﹤0.01% 1748
2021
Q1 		– Sell
-1,993
Closed -$345K – 2706
2020
Q4 		$345K Buy
1,993
+121
+6% +$16.6K ﹤0.01% 2071
2020
Q3 		$208K Buy
+1,872
New +$150K ﹤0.01% 2240
2020
Q2 		– Sell
-5,432
Closed -$365K – 2535
2020
Q1 		$365K Sell
5,432
-3,540
-39% -$280K ﹤0.01% 1741
2019
Q4 		$756K Buy
+8,972
New +$724K ﹤0.01% 1594

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Truist Financial's NVCR Position: Q3 2025 in Review

Truist Financial sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 12,795 shares — an estimated $228K sold.

Truist Financial first reported a position in NVCR in Q4 2019 and held it in 12 quarters. The position peaked at $849K in Q4 2022. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Truist Financial reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • Truist Financial sold 12,795 NovoCure shares in Q3 2025, an estimated $228K.
  • Truist Financial first reported a position in NovoCure in Q4 2019 and held it in 12 quarters.
  • Truist Financial's NovoCure position peaked at $849K in Q4 2022.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Truist Financial's 13F filing for Q3 2025, filed 3 Nov 2025.